Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

Dendritic cell (DC)-based vaccination for cancer treatment has seen considerable development over recent decades. However, this field is currently in a state of flux toward niche-applications, owing to recent paradigm-shifts in immuno-oncology mobilized by T cell-targeting immunotherapies. DC vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Laureano, Raquel S, Sprooten, Jenny, Vanmeerbeerk, Isaure, Borras, Daniel M, Govaerts, Jannes, Naulaerts, Stefan, Berneman, Zwi N, Beuselinck, Benoit, Bol, Kalijn F, Borst, Jannie, Coosemans, an, Datsi, Angeliki, Fučíková, Jitka, Kinget, Lisa, Neyns, Bart, Schreibelt, Gerty, Smits, Evelien, Sorg, Rüdiger V, Spisek, Radek, Thielemans, Kris, Tuyaerts, Sandra, De Vleeschouwer, Steven, de Vries, I Jolanda M, Xiao, Yanling, Garg, Abhishek D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255073/
https://www.ncbi.nlm.nih.gov/pubmed/35800158
http://dx.doi.org/10.1080/2162402X.2022.2096363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255073/
https://www.ncbi.nlm.nih.gov/pubmed/35800158
http://dx.doi.org/10.1080/2162402X.2022.2096363

Ejemplares similares